...
首页> 外文期刊>The biochemical journal >The human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1 (CD-36 and LIMPII analogous 1)-mediated selective cholesteryl ester uptake
【24h】

The human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1 (CD-36 and LIMPII analogous 1)-mediated selective cholesteryl ester uptake

机译:人乳腺癌细胞系HBL-100通过CLA-1(CD-36和LIMPII类似物1)介导的选择性胆固醇酯摄取,从高密度脂蛋白中获取外源胆固醇

获取原文
           

摘要

pAberrant cell proliferation is one of the hallmarks of carcinogenesis, and cholesterol is thought to play an important role during cell proliferation and cancer progression. In the present study we examined the pathways that could contribute to enhanced proliferation rates of HBL-100 cells in the presence of apolipoprotein E-depleted high-density lipoprotein subclass 3 (HDLsub3/sub). When HBL-100 cells were cultivated in the presence of HDLsub3/sub (up to 200 iμ/ig/ml HDLsub3/sub protein), the growth rates and cellular cholesterol content were directly related to the concentrations of HDLsub3/sub in the culture medium. In principle, two pathways can contribute to cholesterol/cholesteryl ester (CE) uptake from HDLsub3/sub, (i) holoparticle- and (ii) scavenger-receptor BI (SR-BI)-mediated selective uptake of HDLsub3/sub-associated CEs. Northern- and Western-blot analyses revealed the expression of CLA-1 (CD-36 and LIMPII analogous 1), the human homologue of the rodent HDL receptor SR-BI. In line with CLA-1 expression, selective uptake of HDLsub3/sub-CEs exceeded HDLsub3/sub-holoparticle uptake between 12- and 58-fold. Competition experiments demonstrated that CLA-1 ligands (oxidized HDL, oxidized and acetylated low-density lipoprotein and phosphatidylserine) inhibited selective HDLsub3/sub-CE uptake. In line with the ligand-binding specificity of CLA-1, phosphatidylcholine did not compete for selective HDLsub3/sub-CE uptake. Selective uptake was regulated by the availability of exogenous cholesterol and PMA, but not by adrenocorticotropic hormone. HPLC analysis revealed that a substantial part of HDLsub3/sub-CE, which was taken up selectively, was subjected to intracellular hydrolysis. A potential candidate facilitating extralysosomal hydrolysis of HDLsub3/sub-CE is hormone-sensitive lipase, an enzyme which was identified in HBL-100 cells by Western blots. Our findings demonstrate that HBL-100 cells are able to acquire HDL-CEs via selective uptake. Subsequent partial hydrolysis by hormone-sensitive lipase could provide ‘free’ cholesterol that is available for the synthesis of cellular membranes during proliferation of cancer cells./p
机译:>异常细胞增殖是致癌作用的标志之一,胆固醇被认为在细胞增殖和癌症发展过程中起着重要作用。在本研究中,我们研究了在载脂蛋白E耗尽的高密度脂蛋白亚类3(HDL 3 )存在下可能有助于提高HBL-100细胞增殖速率的途径。当在HDL 3 (高达200 g / ml HDL 3 蛋白)存在下培养HBL-100细胞时,其生长速率细胞胆固醇和细胞胆固醇含量与培养基中HDL 3 的浓度直接相关。原则上,两种途径可促进HDL 3 吸收胆固醇/胆固醇酯(CE),(i)整体粒子和(ii)清道夫-受体BI(SR-BI)介导的对LDL的选择性吸收HDL 3 关联的CE。 Northern和Western印迹分析显示了CLA-1(CD-36和LIMPII类似物1)的表达,CLA-1是啮齿动物HDL受体SR-BI的人类同源物。与CLA-1表达一致,对HDL 3 -CEs的选择性摄取超过了HDL 3 -完整颗粒的摄取,为12-58倍。竞争实验表明,CLA-1配体(氧化的HDL,氧化和乙酰化的低密度脂蛋白和磷脂酰丝氨酸)抑制了HDL 3 -CE的选择性摄取。与CLA-1的配体结合特异性一致,磷脂酰胆碱不竞争选择性HDL 3 -CE的摄取。选择性摄取受外源胆固醇和PMA的可用性调节,但不受促肾上腺皮质激素的调节。 HPLC分析表明,选择性吸收的HDL 3 -CE的很大一部分经历了细胞内水解。可能促进HDL 3 -CE的体液外水解的是激素敏感性脂肪酶,这是一种通过Western印迹在HBL-100细胞中鉴定的酶。我们的发现表明,HBL-100细胞能够通过选择性摄取获得HDL-CE。随后,激素敏感性脂肪酶会部分水解,可提供“游离”胆固醇,可用于癌细胞增殖期间细胞膜的合成。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号